HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Imidafenacin

HCID 6433090
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
170105-16-5
Standard SMILES
Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1
InChIKey
SQKXYSGRELMAAU-UHFFFAOYSA-N
Molecular formula
C20H21N3O
Average molar mass
319.4 g/mol
Monoisotopic mass
319.1684623

Overview

Imidafenacin is a diarylmethane.

Names & identifiers

Preferred name
Imidafenacin
IUPAC
4-(2-methylimidazol-1-yl)-2,2-diphenylbutanamide
English name
Imidafenacin
Molecular formula
C20H21N3O
Molecular weight
319.4

Names & synonyms

Imidafenacin170105-16-5UritosStaybla4-(2-Methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamideKRP-197XJR8Y07LJOImidafenacinaImidafenacineONO-8025DTXSID00870104imidafenacinum
Show more names
ONO 8025MidanacinMidanasine4-(2-methyLMidana new API)-2,2-diphenyLImidafenacin-d10
RefChem:790619DTXCID40817932Imidafenacin [INN]4-(2-Methyl-1-imidazolyl)-2,2-diphenylbutanamide4-(2-methylimidazol-1-yl)-2,2-diphenylbutanamideMFCD09833703KRP-197;ONO-8025s5385

Database identifiers

CAS
170105-16-5
PubChem CID
6433090
DTXSID
DTXSID00870104
ChEMBL
CHEMBL53366
ChEBI
CHEBI:134720
UNII
XJR8Y07LJO
EC Number
689-703-7
Nikkaji
J1.195.655F

Properties

Computed structural propertiesFilling in

XLogP
2.7
Topological polar surface area
60.9 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
6
Heavy atoms
24
Formal charge
0
Complexity
395

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP1.79

Physicochemical properties

Melting point
184 · 184-187°C
Boiling point
579.7 · 579.7±50.0 °C(Predicted)
Density
1.12 · 1.12±0.1 g/cm3(Predicted)
storage temp.
Sealed in dry,Room Temperature
solubility
DMSO, Methanol
pka
15.72 · 15.72±0.50(Predicted)
form
Solid
color
White
InChI
InChI=1S/C20H21N3O/c1-16-22-13-15-23(16)14-12-20(19(21)24,17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-11,13,15H,12,14H2,1H3,(H2,21,24)
InChIKey
SQKXYSGRELMAAU-UHFFFAOYSA-N
SMILES
N1(CCC(C2=CC=CC=C2)(C2C=CC=CC=2)C(N)=O)C=CN=C1C

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H335-H302-H319-H315
Precautionary statements
P264-P270-P301+P312-P330-P501-P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P

Chemistry & industry

Pharmacology

ATC Code · 2 items

G - Genito urinary system and sex hormones

QG - Genito urinary system and sex hormones

Protein BindingImidafenacin is 88% bounf by human plasma proteins. It binds to serum albumin and α1-acid glycoprotein.
PharmacodynamicsImidafenacin is an antimuscarinic agent which acts to reduce the frequency of urination in patients with overactive bladder.
Mechanism of Action · 1 item

Imidafenacin binds to and antagonizes muscarinic M1 and M3 receptors with high affinity. It also antagonizes muscarinic M2 receptors but with lower affinity. M3 receptors stimulate contraction of the detrusor muscle in the bladder via release of calcium from the sarcoplasmic reticulum. M2 receptors are also present in the detrusor muscle but serve to inhibit adenylate cyclase which reduces the relaxation mediated by β adrenergic receptors. Finally, M1 receptors are present on the parasympathetic neurons which release acetylcholine in the bladder. They act as an autocrine positive feedback loop and further increase release of acetylcholine. Antagonism of these receptors by imidafenacin prevents contraction of the bladder's detrusor muscle, prevents inhibition of the relation produced by sympathetic tone, and reduces acetylcholine release. Together these reduce the frequency of urination.

Biological Half-LifeThe half life of elimination is 3 h.
Metabolism/MetabolitesThought to be metabolized v by CYP3A4 and UGT1A4. No active metabolites have been observed.
Absorption, Distribution and Excretion · 4 items

The absolute oral bioavailability is 57.8%. Tmax is 1-3 h after administration.

10% is excreted in the urine as the parent compound. Most is eliminated by metabolism thought to be mediated by CYP3A4 and UGT1A4.

The estimated volume of distribution is 43.9 L.

The estimated clearance is 21.2 L/h.

Related reactions

1 records
New reaction record
HRID 252623 reaction equation
HRID 252623As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
FDA UNII
8 Y07LJO · XJR8Y07LJO
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
335 · H335-H302-H319-H315
Precautionary statements
264 · P264-P270-P301+P312-P330-P501-P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P
Applications · 3 items

DescriptionImidafenacin, an M3/M1 muscarinic receptor antagonist, was introduced in Japan for the oral treatment of OAB. The majority of OAB symptoms are thought to result from overactivity of the detrusor muscle, which is primarily mediated by acetylcholine-induced stimulation of muscarinic M3 receptors in the bladder. Previously marketed muscarinic antagonists for OAB include propiverine, tolterodine, oxybutynin, trospium, darifenacin, and solifenacin. In vitro, imidafenacin is equally active against M1 and M3 receptors (Kb=0.32 and 0.55nM, respectively), and approximately 10-fold less active against M2 receptors (Kb=4.13nM). Imidafenacin is chemically synthesized in three steps starting with alkylation of diphenylacetonitrile with dibromoethane, followed by condensation with 2-methylimidazole, and hydrolysis of the cyano group to a carboxamide group with 70% sulfuric acid.

UsesA novel therapeutic agent for overactive bladder with antimuscarinic activity, on mediator release from urothelium and detrusor overactivity induced by cerebral infarction. A muscarinic antagonist.

UsesImidafenacin-d10 is deutirium labelled imidafenacin which is a novel therapeutic agent for overactive bladder with antimuscarinic activity, on mediator release from urothelium and detrusor overactivity induced by cerebral infarction.

Additional notes

DefinitionChEBI: Imidafenacin is a diarylmethane.